A novel herpes vector for the high-efficiency transduction of normal and malignant human hematopoietic cells

Blood

Volumn 89, Issue 1, 1997, Pages 119-127

  Dilloo, Dagmar ^b   Rill, Donna ^b   Entwistle, Claire ^b   Boursnell, Michael ^b   Zhong, Wanyun ^b   Holden, William ^b   Holladay, Martha ^b   Inglis, Stephen ^b   Brenner, Malcolm ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLONING VECTOR; CONTROLLED STUDY; GENE TRANSFER; HEMATOPOIETIC CELL; HERPES SIMPLEX VIRUS; HUMAN; HUMAN CELL; IMMUNOSTIMULATION; PRIORITY JOURNAL;

EID: 0031019747     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v89.1.119.119_119_127     Document Type: Article

References (45)

1. Miller AD: Retroviral vectors. Curr Top Microbiol Immunol 158:1, 1992
2. Fearon ER, Pardoe DM, Itaya T, Golumbek P, Levitsky HI, Simons JW, Karasuyama H, Vogelstein B, Frost P: Interleukin-2 production by tumor cells bypasses T helper function in the generation of an antitumor response. Cell 60:397, 1990
3. Gansbacher B, Houghton A, Livingston P, Minasian L, Rosenthal F, Gilboa E, Golde D, Oettgen H, Steffens T, Yang SY, Wong G: A pilot study of immunization with HLA-A2 matched allogeneic melanoma cells that secrete Interleukin-2 in patients with metastatic melanoma. Hum Gene Ther 3:677, 1992
4. Nabel GJ, Nabel EG, Yang ZY, Fox BA, Plautz GE, Gao X, Huang L, Shu S, Gordon D, Chang AE: Direct gene transfer with DNA-liposome complexes in melanoma: Expression, biologic activity, and lack of toxicity in humans. Proc Natl Acad Sci USA 90:11307, 1993
5. Gottesman MM: Report of a meeting: Molecular basis of cancer therapy. J Natl Cancer Inst 86:1277. 1994
6. Pines J: Cyclins, CDKs and cancer. Semin Cancer Biol 6:63, 1995
7. Cordon-Cardo C: Mutations of cell cycle regulators. Biological and clinical implications for human neoplasia. Am J Pathol 147:545, 1995
8. Marcola D, Cohen JS: Antisense approaches to cancer gene therapy. Cancer Gene Ther 2:47, 1995
9. Favrot MC, Combaret V, Goillot E, Tabone E, Bouffet E, Dolbeau D, Bouvier R, Coze C, Michon J, Philip T: Expression of leucocyte adhesion molecules on 66 clinical neuroblastoma specimens. Int J Cancer 44:502, 1991
10. Mitani K, Graham FL, Caskey CT: Transduction of human bone marrow by adenoviral vector. Hum Gene Ther 5:941, 1994
11. Mineta T, Rabkin SD, Martuza RL: Treatment of malignant gliomas using ganciclovir-hypersensitive, ribonucleotide reductase-deficient herpes simplex viral mutant. Cancer Res 54:3963, 1994
12. Kaplitt MG, Tjuvajev JG, Leib DA, Berk J, Pettigrew KD, Posner JB, Pfaff DW, Rabkin SD, Blasberg RG: Mutant herpes simplex virus induced regression of tumors growing in imunocompetent rats. J Neuro Oncol 19:137, 1994
13. Breakefield XO, DeLuca NA: Herpes simplex virus for gene delivery to neurons. New Biol 3:203, 1991
14. Glorioso JC, Bender MA, Coins WF, Fink DJ, DeLuca N: Herpes simplex virus as a gene-delivery vector for the central nervous system, in Kaplitt MG, Loewy AD (eds): Viral Vectors: Gene Therapy and Neuroscience Applications. New York, NY, Academic, 1995, p 1
15. Hunter W, Rabkin S, Martuza R: Brain tumor therapy using genetically engineered replication-competent virus, in Anonymous Viral Vectors, New York, NY, Academic, 1995, p 259
16. Forrester A, Farrell H, Wilkinson G, Kaye J, Davis-Poynter N, Minson T: Construction and properties of a mutant of herpes simplex virus type I with glycoprotein H coding sequences deleted. J Virol 66:341. 1992
17. McLean CS, Erturk M, Jennings R, Challanain DN, Minson AC, Duncan I, Boursnell MEG, Inglis SC: Protective vaccination against primary and recurrent disease caused by herpes simplex virus (HSV) type 2 using a genetically disabled HSV-1. J Infect Dis 170:1100, 1994
18. Manabe A, Coustan-Sinith E, Behm FG, Raimondi SC, Campana D: Bone marrow-derived stromal cells prevent apoptotic cell death in B-lineage acute lymphoblastic leukemia. Blood 79:2370, 1992
19. Kim KJ, Kanellopoulos-Langevin C, Merwin RM, Sachs DH, Asofsky R: Establishment and characterization of BALB/c lymphoma lines with B cell properties. J Immunol 122:549, 1979
20. Nolan GP, Fiering S, Nicolas JF, Herzenberg LA: Flourescence-activated cell analysis and sorting of viable mammalian cells based on β-D-galactosidase activity after transduction of Escherichia coli lacZ. Proc Natl Acad Sci USA 85:2603, 1988
21. Fiering SN, Roederer M, Nolan GP, Micklem DR, Parks DR, Herzenberg LA: Improved FACS-Gal: Flow cytometric analysis and sorting of viable eukaryotric cells expressing reporter gene constructs. Cytometry 12:291, 1991
22. Skaliter R, Lehman IR: Rolling circle DNA replication in vitro by a complex of herpes simplex virus type 1-encoded enzymes. Proc Natl Acad Sci USA 91:10665, 1994
23. Heslop HE, Brenner MK, Krance RA, Bowman L, Cunningham JM, Richardson S, Alexander B, Heideman R, Boyett JM, Srivastava D, Marcus SG, Berenson R, Heimfeld S, Brown S: Use of double marking with retroviral vectors to determine rate of reconstitution of untreated and cytokine expanded CD34+ selected marrow cells in patients undergoing autologous bone marrow transplantation. Hum Gene Ther 7:655, 1996
24. Dranoff G, Jaffee E, Lazenby A, Golumbek P, Levitsky H, Brose K, Jackson V, Hamada H, Pardoll D, Mulligan R: Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity. Proc Natl Acad Sci USA 90:3539, 1993
25. Anderson WF: Human gene therapy. Science 256:808, 1992
26. Brenner MK, Rill DR, Holladay MS, Heslop HE, Moen RC, Buschle M, Krance RA, Santana VM, Anderson WF, Ihle JN: Gene marking to determine whether autologous marrow infusion restores long-term haemopoiesis in cancer patients. Lancet 342:1134, 1993
27. Williams DA: Expression of introduced genetic sequences in hematopoietic cells following retroviral-mediated gene transfer. Hum Gene Ther 2:229. 1990
28. Dunbar CE, Cottler-Fox M, O'Shaunessy JA, Doren S, Carter C, Berenson R, Brown S, Moen RC, Greenblatt J, Stewart FM, Leitman SF, Wilson WH, Cowan K, Young NS, Nienhuis AW: Retrovirally marked CD34-enriched peripheral blood and marrow cells contribute to long-term engraftment after autologous transplantation. Blood 85:3048, 1995
29. Brenner MK, Rill DR, Moen RC, Krance RA, Mirro J Jr, Anderson WF, Ihle JN: Gene-marking to trace origin of relapse after autologous bone marrow transplantation. Lancet 341:85, 1993
30. Deisseroth AB, Zu Z, Claxton D, Hanania EG, Fu S, Ellerson D, Goldberg L, Thomas M, Janicek J, Anderson WF, Hester J, Korbling M, Durett A, Moen R, Berenson R, Heimfeld S, Hamer J, Calvert L, Tibbits P, Talpaz M, Kantarjian H, Champlin R, Reading C: Genetic marking shows that Ph+ cells present in autoiogous transplants of chronic myelogenous leukemia (CML) contribute to relapse after autologous bone marrow in CML. Blood 83:3068, 1994
31. Moritz T, Mackay W, Feng LJ, Samson L, Williams DA: Gene transfer of O6-methylguanine methyltransferase (MGMT) protects hematopoietic cells (HC) from nitrosourea (NU) induced toxicity in vitro and in vivo. Blood 82:118a, 1993 (abstr, suppl 1)
32. Dunbar CE, Bodine DM, Sorrentino B, Donahue R, Cottler-Fox M, O'Shaughnessy J, Cowan K, Carter C, Doren S, Cassel A, Nienhuis AW: Gene transfer into hematopoietic cells: Implications for cancer therapy. Ann NY Acad Sci 716:216, 1994
33. Brenner MK: The use of cytokines to improve gene transfer to human hematopoietic stem cells. Cytokine and Molec Ther 1:3, 1995
34. Muzyczka N: Use of adeno-associated virus as a general transduction vector for mammalian cells. Curr Top Microbiol Immunol 158:97, 1992
35. Huang S, Endo RI, Nemerow GR: Upregulation of integrins alpha v beta 3 and alpha v beta 5 on human inonocytes and T lymphocytes facilitates adenovirus-mediated gene delivery. J Virol 69:2257, 1995
36. Tepper RI, Mule JJ: Experimental and clinical studies of cytokine gene-modified tumor cells. Hum Gene Ther 5:153, 1994
37. Culver KW, Ram Z, Wallbridge S, Ishii H, Oldfield EH, Blaese RM: In vivo gene transfer with retroviral vector-producer cells for treatment of experimental brain tumors. Science 256:1550, 1992
38. Mavilio F, Ferrari G, Rossini S, Nobili N, Bonini C, Casorati G, Traversari C, Bordignon C: Peripheral blood lymphocytes as target cells of retroviral vector-mediated gene transfer. Blood 83:1988, 1994
39. Tiberghien P, Reynolds CW, Keller J, Spence S, Deschaseaux M, Certoux J, Contassot E, Murphy WJ, Lyons R, Chiang Y, Herve P, Longo DL, Ruscetti FW: Ganciclovir treatment of herpes simplex thymidine kinase-transduced primary T lymphocytes: An approach for specific in vivo donor T-cell depletion after bone marrow transplantation? Blood 84:1333, 1994
40. Hayward A, Laszlo M, Turman M, Vafai A, Tedder D: Nonproductive infection of human newborn blood mononuclear cells with herpes simplex virus: Effect on T cell activation, IL-2 production and proliferation. Clin Exp Immunol 74:196, 1988
41. Smith TA, Mehaffey MG, Kayda DB, Saunders JM, Yei S, Trapnell BC, McClelland A, Kaleko M: Adenovirus mediated expression of therapeutic plasma levels in human factor IX in mice. Nat Genet 5:397, 1993
42. Amin R, Wilmott R, Schwarz Y, Trapnell B, Stark J: Replication-deficient adenovirus induces expression of interleukin-8 by airway epithelial cells in vivo. Hum Gene Ther 6:145, 1995
43. Corey L, Spear PG: Infections with herpes simplex viruses. N Engl J Med 314:749, 1986
44. Leib DA, Olivo PD: Gene delivery to neurons: Is herpes simplex virus the right tool for the job? BioEssays 15:547, 1993
45. Spaete R, Frenkel N: The herpes virus amplicon: A new eucaryotic defective-virus cloning-amplifying vector. Cell 30:295, 1982